Rockwell Medical, Inc. (RMTI) vs SCYNEXIS, Inc. (SCYX)
Rockwell Medical, Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $45.0M against $34.5M — 1.3× the size. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against −21.1%. Rockwell Medical, Inc. has the higher net margin (−7.33% vs −49.7%) and the higher return on invested capital (−14.6% vs −110.7%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 10 and SCYNEXIS, Inc. on 8.
Valuation
Profitability
| Metric | RMTI | SCYX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 17.71% | 100.00% | 53.94% |
| Operating margin | (6.52%) | (109.90%) | 0.00% |
| Net margin | (7.33%) | (49.74%) | 0.00% |
| Free cash flow margin | 2.47% | (64.67%) | 0.00% |
| Return on equity | (15.53%) | (18.38%) | (0.40%) |
| Return on assets | (9.32%) | (15.09%) | (3.32%) |
| Return on invested capital | (14.58%) | (110.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack